Efficacy and safety of empagliflozin in people with type 2 diabetes during Ramadan fasting.
Diabetes & Metabolic Syndrome: Clinical Research & Reviews（2022）
摘要
Empagliflozin was found to be safe and effective in fasting people with T2DM. Further large-scale studies are needed to validate our findings.
更多查看译文
关键词
Complications,Empagliflozin,Ramadan fasting,type2 diabetes mellitus
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要